The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy® (semaglutide) for adults who may need extra help losing weight. It is now approved in all 27 countries ...

Researchers from the University of Missouri School of Medicine have shed light on what populations are more likely to be prescribed a high dose of opioid medication. This increases their risk of ...

High-dose oral insulin did not reduce risk for progression to type 1 diabetes among children with stage 1 disease, according to data from a phase 2 trial published in Diabetes Care. In the Fr1da ...

Patients on the higher dose of 7.2 milligrams for about 18 months lost 21% of their body weight on average, a study found.

The thought of accidental pregnancy is, to put it mildly, a bummer. But one factor that women who face this situation might not consider is how their weight might effect their options. Recently, a ...

The “skinny jab” Wegovy may be about to get more potent – after a trial found a triple-strength dose leads to 19 per cent weight loss, without unexpected side effects. The result came from a trial of ...

CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application ...

Biogen BIIB announced that the FDA has issued a complete response letter (CRL) to its supplemental new drug application (sNDA) seeking label expansion for a higher dose of its renowned spinal muscular ...